274 related articles for article (PubMed ID: 16029529)
21. Clinical features and outcomes of anti-glomerular basement membrane disease in older patients.
Cui Z; Zhao J; Jia XY; Zhu SN; Zhao MH
Am J Kidney Dis; 2011 Apr; 57(4):575-82. PubMed ID: 21168945
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical characterization of glomerular inflammatory cells and expression of adhesion molecules in anti-glomerular basement membrane (anti-GBM) glomerulonephritis induced in WKY rats with monoclonal anti-GBM antibodies of different subclasses.
Kado T; Kohda T; Okada S; Hayashi A; Utsunomiya Y; Kanzaki S; Sado Y; Yamamoto T
Pathol Int; 2006 Feb; 56(2):55-61. PubMed ID: 16445816
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J; Vizjak A; Ferluga D; Kovac D; Ales A; Kveder R; Ponikvar R; Bren A
Ther Apher Dial; 2009 Aug; 13(4):278-81. PubMed ID: 19695059
[TBL] [Abstract][Full Text] [Related]
24. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
[TBL] [Abstract][Full Text] [Related]
25. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A; Slot M; van Paassen P; van Breda Vriesman P; Heeringa P; Tervaert JW
Am J Kidney Dis; 2005 Aug; 46(2):253-62. PubMed ID: 16112043
[TBL] [Abstract][Full Text] [Related]
26. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat.
Reynolds J; Prodromidi EI; Juggapah JK; Abbott DS; Holthaus KA; Kalluri R; Pusey CD
J Am Soc Nephrol; 2005 May; 16(5):1350-9. PubMed ID: 15814836
[TBL] [Abstract][Full Text] [Related]
27. Purification of alpha chain NC1 domains of type IV collagen from bovine kidney and their application in ELISA for detecting anti-glomerular basement membrane antibodies.
Xin G; Zhao M; Ding J; Wang H
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 35(5):494-8. PubMed ID: 14601306
[TBL] [Abstract][Full Text] [Related]
28. Performance evaluation of a novel chemiluminescence assay for detection of anti-GBM antibodies: an international multicenter study.
Mahler M; Radice A; Sinico RA; Damoiseaux J; Seaman A; Buckmelter K; Vizjak A; Buchner C; Binder WL; Fritzler MJ; Cui Z
Nephrol Dial Transplant; 2012 Jan; 27(1):243-52. PubMed ID: 21562146
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of antithyroid antibodies in anti-glomerular basement membrane antibody-mediated disease.
Ara J; Robert J; Mirapeix E; Botey A; Darnell A
J Nephrol; 2000; 13(1):65-7. PubMed ID: 10720217
[TBL] [Abstract][Full Text] [Related]
30. The uncertain significance of anti-glomerular basement membrane antibody among HIV-infected persons with kidney disease.
Szczech LA; Anderson A; Ramers C; Engeman J; Ellis M; Butterly D; Howell DN
Am J Kidney Dis; 2006 Oct; 48(4):e55-9. PubMed ID: 16997046
[TBL] [Abstract][Full Text] [Related]
31. Immunological properties of the human Goodpasture target antigen.
Weber M; Meyer zum Büschenfelde KH; Köhler H
Clin Exp Immunol; 1988 Nov; 74(2):289-94. PubMed ID: 3224445
[TBL] [Abstract][Full Text] [Related]
32. Glomerular basement membrane antibodies in hantavirus disease (hemorrhagic fever with renal syndrome).
Billheden J; Boman J; Stegmayr B; Wieslander J; Settergren B
Clin Nephrol; 1997 Sep; 48(3):137-40. PubMed ID: 9342483
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a non-Goodpasture autoantibody to type IV collagen.
Johansson C; Butkowski R; Swedenborg P; Alm P; Wieslander J
Nephrol Dial Transplant; 1993; 8(11):1205-10. PubMed ID: 8302456
[TBL] [Abstract][Full Text] [Related]
34. Alveolar haemorrhage in anti-glomerular basement membrane disease without detectable antibodies by conventional assays.
Serisier DJ; Wong RC; Armstrong JG
Thorax; 2006 Jul; 61(7):636-9. PubMed ID: 16807392
[TBL] [Abstract][Full Text] [Related]
35. [The distribution and clinical significance of IgG subclasses of anti-glomerular basement membrane antibodies].
Yan Y; Cui Z; Zhao MH
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):501-4. PubMed ID: 15489931
[TBL] [Abstract][Full Text] [Related]
36. Induction of Goodpasture antibodies to noncollagenous domain (NC1) of type IV collagen in mice by idiotypic manipulation.
Shoenfeld Y; Gilburd B; Hojnik M; Damianovich M; Hacham S; Kopolovic Y; Polak-Charcon P; Goldberg I; Afek A; Hun-Chi L
Hum Antibodies Hybridomas; 1995; 6(4):122-8. PubMed ID: 8688494
[TBL] [Abstract][Full Text] [Related]
37. Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-glomerular basement membrane disease.
Xin G; Cui Z; Su Y; Xu LX; Zhao MH; Li KS
Nephrology (Carlton); 2013 Mar; 18(3):209-14. PubMed ID: 23317407
[TBL] [Abstract][Full Text] [Related]
38. Crescentic transformation in primary membranous glomerulopathy: association with anti-GBM antibody.
Nayak SG; Satish R
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):599-602. PubMed ID: 17951950
[TBL] [Abstract][Full Text] [Related]
39. Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease.
O'Donoghue DJ; Short CD; Brenchley PE; Lawler W; Ballardie FW
Clin Nephrol; 1989 Dec; 32(6):251-5. PubMed ID: 2612068
[TBL] [Abstract][Full Text] [Related]
40. Immunofluorescence study of type IV collagen alpha chains in epidermal basement membrane: application in diagnosis of X-linked Alport syndrome.
Ding J; Yang J; Liu J; Yu L
Chin Med J (Engl); 1997 Aug; 110(8):584-6. PubMed ID: 9594257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
